Hong Kong said recently it had approved a version of the BioNTech COVID-19 vaccine for babies and children under five years old, part of broader measures to boost vaccination uptake in the financial hub.
The government said it was discussing with the vaccine manufacturer the timeframe for when it would be available in the Chinese special administrative region. The government has said that each shot contains one-tenth of the adult dosage, reducing the chance of side effects.
The government approved the use of China’s Sinovac shots for children aged six months and older in August. Sinovac and BioNTech are the two vaccines available for Hong Kong residents.
Hong Kong has included children five years and older in the government’s vaccine pass programme, which requires them to have two doses by 30th November, the government said.
Edits by EP News Bureau